Individualised treatment in alcohol-dependent patients

European Archives of Psychiatry and Clinical Neuroscience

Volumn 260, Issue SUPPL. 2, 2010, Pages

  Mann, Karl ^a   Hermann, Derik ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Acamprosate; Alcohol dependence; Individualised psychotherapy; Individualised treatment; Naltrexone

Indexed keywords

ACAMPROSATE; DISULFIRAM; GLUTAMIC ACID; MU OPIATE RECEPTOR; NALTREXONE;

ALCOHOLISM; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; CONFERENCE PAPER; DNA POLYMORPHISM; DRUG RESPONSE; EXPOSURE; HUMAN; INDIVIDUALIZATION; INTERVIEW; MENTAL DISEASE; MOTIVATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATIENT COUNSELING; PRIORITY JOURNAL; PSYCHOTHERAPY; RECEPTOR GENE; REINFORCEMENT; RELAPSE; SELF MONITORING; SOCIAL BEHAVIOR; SOCIAL NETWORK;

ALCOHOL DETERRENTS; ALCOHOLISM; BRAIN; HUMANS; INDIVIDUALIZED MEDICINE; MAGNETIC RESONANCE SPECTROSCOPY; META-ANALYSIS AS TOPIC; PSYCHOTHERAPY;

EID: 78449290587     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-010-0153-7     Document Type: Conference Paper

References (29)

1. Institute of Medicine (1990) Broadening the base of treatment for alcohol problems. National Academy Press, Washington
2. Project MATCH Research Group 1993 Project match (matching alcoholism treatment to client heterogeneity): rationale and methods for a multisite clinical trial matching patients to alcoholism treatment Alcohol Clin Exp Res 17 1130 1145 10.1111/j.1530-0277.1993.tb05219.x
3. Project MATCH Research Group 1998 Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment J Stud Alcohol 59 631 639
4. UKATT Research Team 2001 United Kingdom alcohol treatment trial (UKATT): hypotheses, design and methods Alcohol Alcohol 36 11 21
5. A Copello J Orfor R Hodgson G Tober C Barrett UKATT Research Team 2002 United Kingdom alcohol treatment trial. Social behaviour and network therapy basic principles and early experiences Addict Behav 27 345 366 10.1016/S0306-4603(01)00176-9 12118625 (Pubitemid 34303323)
6. UKATT Research Team 2005 Effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT) BMJ 331 541 10.1136/bmj.331.7516.541
7. UKATT Research Team 2008 UK alcohol treatment trial: client-treatment matching effects Addiction 103 228 238 10.1111/j.1360-0443.2007.02060.x
8. UKATT Research Team 2005 Cost effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT) BMJ 331 544 10.1136/bmj.331.7516.544
9. Vollstädt-Klein S, Loeber S, Kirsch M, Richter A, Bühler M, von der Goltz C, Hermann D, Mann K, Kiefer F (2010) Effects of cue-exposure treatment on neural cue-reactivity in alcohol-dependence: a randomized trial. Biol Psych (in press)
10. K Mann P Lehert MY Morgan 2004 The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis Alcohol Clin Exp Res 28 51 63 10.1097/01.ALC.0000108656.81563.05 14745302 (Pubitemid 38114023)
11. M Srisurapanont N Jarusuraisin 2005 Opioid antagonists for alcohol dependence Cochrane Database Syst Rev 25 1 CD001867
12. M Soyka S Rösner 2008 Opioid antagonists for pharmacological treatment of alcohol dependence-a critical review Curr Drug Abuse Rev 1 280 291 1:CAS:528:DC%2BD1cXhtlems7bL 10.2174/1874473710801030280 19630726
13. F Kiefer H Jahn T Tarnaske H Helwig P Briken R Holzbach P Kampf R Stracke M Baehr D Naber K Wiedemann 2003 Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study Arch Gen Psychiatry 60 92 99 1:CAS:528: DC%2BD3sXovFWltg%3D%3D 10.1001/archpsyc.60.1.92 12511176
14. RF Anton SS O'Malley COMBINE Study Research Group, et al. 2006 Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial JAMA 295 2003 2017 1:CAS:528:DC%2BD28Xkt12mtrc%3D 10.1001/jama.295.17.2003 16670409 (Pubitemid 44794003)
15. C Bond KS LaForge M Tian, et al. 1998 Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction Proc Natl Acad Sci USA 95 9608 9613 1:CAS:528:DyaK1cXltlClsbY%3D 10.1073/pnas.95.16.9608 9689128 (Pubitemid 28506279)
16. SD Mague JA Blendy 2010 OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models Drug Alcohol Depend 108 172 182 1:CAS:528:DC%2BC3cXlsFSns7c%3D 10.1016/j.drugalcdep.2009.12.016 20074870
17. DW Oslin W Berrettini HR Kranzler H Pettinati J Gelernter JR Volpicelli CP O'Brien 2003 A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients Neuropsychopharmacology 28 1546 1552 1:CAS:528:DC%2BD3sXls1Sls78%3D 10.1038/sj.npp.1300219 12813472 (Pubitemid 41070891)
18. RF Anton G Oroszi S O'Malley D Couper R Swift H Pettinati D Goldman 2008 An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the combined pharmacotherapies and behavioral interventions for alcohol dependence (COMBINE) study Arch Gen Psychiatry 65 135 144 1:CAS:528:DC%2BD1cXivVOms7Y%3D 10.1001/archpsyc.65.2.135 18250251 (Pubitemid 351222547)
19. J Treutlein S Cichon M Ridinger, et al. 2009 Genome-wide association study of alcohol dependence Arch Gen Psychiatry 66 773 784 1:CAS:528: DC%2BD1MXptFGksL0%3D 10.1001/archgenpsychiatry.2009.83 19581569
20. Kiefer F, Witt SH, Frank J, Richter A, Treutlein J, Lemenager T et al. (2010) Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate. Pharmacogenomics J. 2010 (in Press)
21. K Mann F Kiefer M Smolka H Gann S Wellek A Heinz PREDICT Study Research Team 2009 Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT study Alcohol Clin Exp Res 33 674 683 1:CAS:528:DC%2BD1MXltVOitbw%3D 10.1111/j.1530-0277.2008.00884.x 19170666
22. A Victorio-Estrada RF Mucha ER Stephan 1996 Excessive drinking situations in German alcoholics: replication of a three-factor model used for North Americans Drug Alcohol Depend 41 75 79 1:STN:280:DyaK28zosFCluw%3D%3D 10.1016/0376-8716(96)01241-0 8793313 (Pubitemid 26185298)
23. GF Koob 2003 Alcoholism: allostasis and beyond Alcohol Clin Exp Res 27 232 243 1:CAS:528:DC%2BD3sXhsVykt7g%3D 10.1097/01.ALC.0000057122.36127.C2 12605072 (Pubitemid 36236646)
24. R Spanagel F Weiss 1999 The dopamine hypothesis of reward: past and current status Trends Neurosci 22 521 527 1:CAS:528:DyaK1MXmvVKhtrg%3D 10.1016/S0166-2236(99)01447-2 10529820 (Pubitemid 29481853)
25. J Littleton 1995 Acamprosate in alcohol dependence: how does it work? Addiction 90 1179 1188 1:STN:280:DyaK28%2FhvFaksQ%3D%3D 10.1111/j.1360-0443. 1995.tb01088.x 7580816
26. K Mann F Kiefer R Spanagel J Littleton 2008 Acamprosate: recent findings and future research directions Alcohol Clin Exp Res 32 1105 1110 1:CAS:528:DC%2BD1cXpvFGntL4%3D 10.1111/j.1530-0277.2008.00690.x 18540918
27. GF Koob M Le Moal 2008 Addiction and the brain antireward system Annu Rev Psychol 59 29 53 10.1146/annurev.psych.59.103006.093548 18154498
28. G Tsai JT Coyle 1998 The role of glutamatergic neurotransmission in the pathophysiology of alcoholism Annu Rev Med 49 173 184 1:CAS:528: DyaK1cXhtFKqsr4%3D 10.1146/annurev.med.49.1.173 9509257 (Pubitemid 28197448)
29. JT Gass MF Olive 2008 Glutamatergic substrates of drug addiction and alcoholism Biochem Pharmacol 75 218 265 1:CAS:528:DC%2BD2sXhsVCksLjL 10.1016/j.bcp.2007.06.039 17706608 (Pubitemid 350235390)